 At Johns Hopkins, I'm Elizabeth Tracy. Diabetes medicines known as GLP-1 agonists and SGL-2 inhibitors are recommended for people with type 2 diabetes in a recent large study that aggregated data from other studies. Rita Kalyani, a diabetes expert at Johns Hopkins, says while there's no doubt these medicines are effective, there is a downside.